Children's Health | Headaches, Phase I-II

A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

Volunteers
Health Professionals

What is the purpose of this trial?

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

Ages
6 years - 17 years
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Lindsie Boerger

lindsie.boerger@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Cristian Ionita, MD
Associate Professor of Pediatrics (Neurology); Director of the Pediatric Neurology Residency Program; Co-Director Yale/MDA Pediatric Neuromuscular Clinic

Sub-Investigator

Cristian Ionita, MD

Last Updated
02/19/2025
Study HIC
#2000028680